| Biotechnology Industry | Healthcare Sector | Mr. Sun Cho Chang CEO | KRX SM Exchange | - ISIN |
| South Korea Country | 248 Employees | - Last Dividend | 22 Apr 2013 Last Split | - IPO Date |
CTCBIO Inc. is a globally recognized entity in the pharmaceutical sector, originating from South Korea and extending its services and products internationally. Founded in 1993, the company has carved a niche for itself in both animal and human pharmaceuticals, leveraging extensive scientific research and innovation to drive its product development. Headquartered in Hwaseong, South Korea, CTCBIO Inc.'s strategic focus encompasses a wide array of health-related areas, from disease management and prevention to health enhancement through functional foods. Their commitment to excellence is reflected not only in their comprehensive product lineup but also in their cutting-edge solutions like the CTC covid-19 IgM/IgG combo test, demonstrating their agility in responding to global health crises.
CTCBIO offers a diverse pharmaceutical portfolio for both human and veterinary use, including treatments for cardiovascular diseases, gastrointestinal disorders, osteoporosis, and infections among others. This segment ensures the availability of quality medicines to enhance health and manage diseases effectively.
Understanding the critical role of nutrition in animal health, CTCBIO provides a range of feed additives and ingredients. These products aim to improve the nutritional value of animal feed, thereby promoting healthier and more productive livestock.
With a growing consumer focus on wellness, CTCBIO’s functional food products are designed to offer health benefits beyond basic nutrition. These include foods enriched with active ingredients that contribute to better health, aid in the prevention of disease, or support the management of chronic conditions.
The company also specializes in the provision of active pharmaceutical ingredients (APIs), alongside excipients such as coating bases, diluting agents, bonding agents, and lubricants that are pivotal in drug formulation.
In response to the global pandemic, CTCBIO developed the CTC covid-19 IgM/IgG combo test, a rapid antibody test kit that provides quick results for COVID-19 testing, showcasing the company's commitment to contributing towards global health security.
Beyond pharmaceuticals for disease treatment, CTCBIO offers a variety of products aimed at enhancing animal health. This includes physiological activators, functional enhancers, and disinfectants, all designed to ensure the well-being of animals.